Table 1.

Patient characteristics at glatiramer acetate start

Characteristic	mITT cohort n = 232	Ongoing cohort n = 100	Withdrawn cohort n = 132
Age at multiple sclerosis disease onset (mean ±SD)	27.40 ± 6.18	28.06 ± 6.31	26.90 ± 6.05
Age (mean ± SD)	35.5 ± 6.4	35.1 ± 5.8	33.8 ± 6.5
Gender (% female)	73%	70%	76%
Mean relapse rate 12 months before GA start	1.18 ± 0.82	1.12 ± 0.82	1.23 ± 0.83
Expanded Disability Status Scale score (mean ± SD)	2.8 ± 1.50	2.5 ± 1.3	3.0 ± 1.6
Disease duration (years, mean±SD)	8.3 ± 5.12	8.4 ± 5.14	8.13 ± 5.12

GA, glatiramer acetate.